Thermo Fisher's third-quarter revenue and earnings beat expectations
Thermo Fisher posted 9% revenue growth and 15% higher adjusted EPS. According to GuruFocus, the shares rose about 2% during Wednesday trading.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Life-sciences tools maker Thermo Fisher Scientific reported third-quarter results on Wednesday. Revenue climbed 9% to $12.14 billion, and adjusted earnings per share rose 15% to $6.68. Organic revenue grew 6%. The adjusted operating margin widened to 24.5% from 23.3%, while GAAP operating income increased 17% to $2.26 billion, according to GuruFocus.
The Life Sciences Solutions division was less impressive. Its revenue reached $2.72 billion, but the operating margin fell to 22.4% from 23.3%. The shares traded at $701.21, up roughly 2.01% around 11:42 a.m. ET, and sat 16.07% above the $604.10 GF Value estimate.
why it matters
The key question for investors is how much of the growth is already priced in. With the stock trading above GuruFocus's fair-value estimate, further margin recovery in Life Sciences Solutions would be needed to support the current valuation.
market impact
Life-sciences tools sector: strong results support growth expectations, but the valuation already looks full
tags
instruments
sources
- Thermo Fisher Stocks Rise 1.0% as Revenue Growth Beats Estimates — gurufocus.com, 21 October 2026 at 18:10 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗